Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,919 | 82,398 | 66,480 | 98,179 | 20,813 |
| Marketable Securities | 1,265 | 1,106 | 1,241 | 34,946 | 46,183 |
| Receivables | 3,637 | 2,985 | 2,453 | 2,582 | 2,861 |
| Other current assets | 0 | 0 | 600 | 10,000 | 0 |
| TOTAL | $42,093 | $89,654 | $71,836 | $146,263 | $71,732 |
| Non-Current Assets | |||||
| PPE Net | 16,958 | 12,707 | 10,083 | 9,203 | 7,436 |
| Investments And Advances | 188,054 | 189,002 | 171,421 | 171,098 | 169,628 |
| Intangibles | 94,372 | 106,314 | 24,205 | 24,316 | 24,427 |
| Other Non-Current Assets | 3,751 | 3,909 | 1,513 | 524 | 556 |
| TOTAL | $303,135 | $311,932 | $207,222 | $205,141 | $202,047 |
| Total Assets | $345,228 | $401,586 | $279,058 | $351,404 | $273,779 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 209 | 5,188 | 5,067 | 4,949 |
| Accounts payable and accrued liabilities | 53,008 | 56,644 | 13,377 | 16,423 | 15,139 |
| Accrued Expenses | 9,159 | 8,306 | 7,308 | 38,593 | 7,422 |
| Other current liabilities | N/A | 248 | N/A | N/A | N/A |
| TOTAL | $71,833 | $76,085 | $36,043 | $61,027 | $28,427 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,083 | 47,107 | 458 | 1,801 | 3,113 |
| Deferred Revenues | 9,666 | 10,678 | 10,170 | 944 | 917 |
| Other Non-Current Liabilities | 5,221 | 4,344 | 7,551 | 8,578 | 8,966 |
| TOTAL | $211,289 | $238,999 | $170,521 | $155,149 | $156,389 |
| Total Liabilities | $283,122 | $315,084 | $206,564 | $216,176 | $184,816 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,309 | 50,887 | 57,940 | 57,570 | 40,213 |
| Common Shares | 6 | 6 | 26 | 7 | 4 |
| Retained earnings | -197,316 | -174,252 | -162,299 | -176,668 | -131,719 |
| Other shareholders' equity | 3,806 | 5,883 | -50,827 | -25,063 | 30,839 |
| TOTAL | $62,106 | $86,502 | $72,494 | $135,228 | $88,963 |
| Total Liabilities And Equity | $345,228 | $401,586 | $279,058 | $351,404 | $273,779 |